IL-28 Activators

Interleukin-28 (IL-28), also known as interferon lambda, is part of a family of cytokines that play a critical role in the innate immune response to viral infections, particularly in the respiratory and gastrointestinal tracts. IL-28, along with its related cytokines IL-28A, IL-28B, and IL-29 (interferon lambda-2 and -3, and interferon lambda-1, respectively), is involved in the antiviral defense mechanism by inducing the expression of interferon-stimulated genes (ISGs) that inhibit viral replication. The action of IL-28 is mediated through its interaction with a specific receptor complex, composed of the interleukin-28 receptor α (IL-28Rα) and interleukin-10 receptor β (IL-10Rβ) subunits. This binding initiates a signaling cascade via the JAK-STAT pathway, leading to the transcription of target genes involved in antiviral, antiproliferative, and immunomodulatory responses. The unique aspect of IL-28 and its family members is their ability to elicit a potent antiviral state in cells that are not typically responsive to type I interferons, such as IFN-α and IFN-β, thereby representing a crucial aspect of the immune response in epithelial barriers.

The activation of IL-28 is tightly regulated and is typically induced by viral infections through pattern recognition receptors (PRRs) such as Toll-like receptors (TLRs) and RIG-I-like receptors (RLRs) that sense viral nucleic acids. Upon recognition of viral components, these receptors trigger signaling pathways that culminate in the transcriptional activation of genes encoding IL-28 and its family members. The production of IL-28 is thus a direct response to viral challenge, aimed at limiting viral spread and establishing an antiviral state within the host. Moreover, the expression and activity of IL-28 are modulated by various factors, including the type and severity of the infection, the presence of other cytokines, and the specific tissue environment. This regulation ensures that IL-28 is precisely activated and deployed at sites of infection, minimizing tissue damage while effectively counteracting viral pathogens. Through these mechanisms, IL-28 serves as a bridge between innate and adaptive immunity, orchestrating a comprehensive and targeted response to viral infections.